Clinical Trial Update: Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 pilot trial of CRLX101 for advanced/metastatic stomach, gastroesophageal junction, or esophageal cancers that are unresectable; trial completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Adenocarcinoma of the Gastroesophageal Junction
• Diffuse Adenocarcinoma of the Stomach
• Esophageal Cancer
• Gastric Cancer
• Intestinal Adenocarcinoma of the Stomach
• Mixed Adenocarcinoma of the Stomach
• Squamous Cell Carcinoma of the Esophagus
• Stage Iiib Esophageal Cancer
• Stage Iiib Gastric Cancer
• Stage Iiic Esophageal Cancer
• Stage Iiic Gastric Cancer

Drugs mentioned

• CRLX101

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 2 | Status: COMPLETED | Results posted: 2017-12-27